Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2013138592) MONITORING AND DELIVERY SYSTEM FOR SUPPLYING PATIENT WITH CONTROLLED DOSAGE OF SUBSTANCE REVERSAL AGENT
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/138592 International Application No.: PCT/US2013/031338
Publication Date: 19.09.2013 International Filing Date: 14.03.2013
IPC:
A61B 5/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
5
Measuring for diagnostic purposes; Identification of persons
08
Measuring devices for evaluating the respiratory organs
Applicants:
OLSON, Lloyd [US/US]; US
Inventors:
OLSON, Lloyd; US
OLSON, Elizabeth; US
Agent:
WALSWORTH, Ian R.; Sheridan Ross P.C. 1560 Broadway Suite 1200 Denver, CO 80202, US
Priority Data:
13/801,86213.03.2013US
61/596,62114.03.2012US
Title (EN) MONITORING AND DELIVERY SYSTEM FOR SUPPLYING PATIENT WITH CONTROLLED DOSAGE OF SUBSTANCE REVERSAL AGENT
(FR) SURVEILLANCE ET SYSTÈME DE DISTRIBUTION POUR FOURNIR À UN PATIENT UN DOSAGE CONTRÔLÉ D'AGENT D'INVERSION DE SUBSTANCES
Abstract:
(EN) The present disclosure involves a system for monitoring patients, and more specifically post-operative patients receiving narcotics/sedatives/opioids, and a novel apparatus for automatically delivering one or more substances such as a reversing agent, including but not limited to the agent commonly known as naloxone, in response to dangerous respiratory conditions such as respiratory depression or other undesired consequences caused by reaction to another dosage being delivered to the subject.
(FR) La présente invention concerne un système de surveillance de patients, et plus spécifiquement de patients postopératoires recevant des narcotiques/sédatifs/opioïdes, et un nouvel appareil pour administrer automatiquement une ou plusieurs substances telles qu'un agent d'inversion, y compris mais sans s'y limiter, l'agent couramment connu sous le nom de naloxone, en réponse à des conditions respiratoires dangereuses, telles que la dépression respiratoire ou d'autres conséquences indésirables provoquée en réaction à une autre dose administrée au sujet.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)